These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38970559)

  • 1. Whole blood transcriptomic signature of Cushing's syndrome.
    Birtolo MF; Armignacco R; Benanteur N; Baussart B; Villa C; De Murat D; Guignat L; Groussin L; Libé R; Zennaro MC; Saidi M; Perlemoine K; Letourneur F; Amar L; Bertherat J; Jouinot A; Assié G
    Eur J Endocrinol; 2024 Jul; 191(1):55-63. PubMed ID: 38970559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of glucocorticoid-related molecular signature by whole blood methylome analysis.
    Armignacco R; Jouinot A; Bouys L; Septier A; Lartigue T; Neou M; Gaspar C; Perlemoine K; Braun L; Riester A; Bonnet-Serrano F; Blanchard A; Amar L; Scaroni C; Ceccato F; Rossi GP; Williams TA; Larsen CK; Allassonnière S; Zennaro MC; Beuschlein F; Reincke M; Bertherat J; Assié G
    Eur J Endocrinol; 2022 Jan; 186(2):297-308. PubMed ID: 34914631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced DNA methylation of FKBP5 in Cushing's syndrome.
    Resmini E; Santos A; Aulinas A; Webb SM; Vives-Gilabert Y; Cox O; Wand G; Lee RS
    Endocrine; 2016 Dec; 54(3):768-777. PubMed ID: 27664120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum steroid profiling in Cushing's syndrome patients.
    Hána V; Ježková J; Kosák M; Kršek M; Hána V; Hill M
    J Steroid Biochem Mol Biol; 2019 Sep; 192():105410. PubMed ID: 31201926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study.
    Chasseloup F; Bourdeau I; Tabarin A; Regazzo D; Dumontet C; Ladurelle N; Tosca L; Amazit L; Proust A; Scharfmann R; Mignot T; Fiore F; Tsagarakis S; Vassiliadi D; Maiter D; Young J; Lecoq AL; Deméocq V; Salenave S; Lefebvre H; Cloix L; Emy P; Dessailloud R; Vezzosi D; Scaroni C; Barbot M; de Herder W; Pattou F; Tétreault M; Corbeil G; Dupeux M; Lambert B; Tachdjian G; Guiochon-Mantel A; Beau I; Chanson P; Viengchareun S; Lacroix A; Bouligand J; Kamenický P
    Lancet Diabetes Endocrinol; 2021 Dec; 9(12):813-824. PubMed ID: 34655521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia.
    Tatsuno I; Uchida D; Tanaka T; Koide H; Shigeta A; Ichikawa T; Sasano H; Saito Y
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):192-200. PubMed ID: 14725680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FKBP5 mRNA Expression Is a Biomarker for GR Antagonism.
    Bali U; Phillips T; Hunt H; Unitt J
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4305-4312. PubMed ID: 27459525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Plasma microRNA to Differentiate Cushing's Disease From Ectopic ACTH Syndrome.
    Belaya Z; Khandaeva P; Nonn L; Nikitin A; Solodovnikov A; Sitkin I; Grigoriev A; Pikunov M; Lapshina A; Rozhinskaya L; Melnichenko G; Dedov I
    Front Endocrinol (Lausanne); 2020; 11():331. PubMed ID: 32582027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients.
    Nunes ML; Vattaut S; Corcuff JB; Rault A; Loiseau H; Gatta B; Valli N; Letenneur L; Tabarin A
    J Clin Endocrinol Metab; 2009 Feb; 94(2):456-62. PubMed ID: 19001518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome.
    Fallo F; Scarda A; Sonino N; Paoletta A; Boscaro M; Pagano C; Federspil G; Vettor R
    Eur J Endocrinol; 2004 Mar; 150(3):339-44. PubMed ID: 15012619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of normal tests assessing hypercortisolism in subjects with mild and episodic Cushing's syndrome suggests that the paradigm for diagnosis and exclusion of Cushing's syndrome requires multiple testing.
    Friedman TC; Ghods DE; Shahinian HK; Zachery L; Shayesteh N; Seasholtz S; Zuckerbraun E; Lee ML; McCutcheon IE
    Horm Metab Res; 2010 Nov; 42(12):874-81. PubMed ID: 20803415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic changes in serum steroids for diagnosing and subtyping Cushing's syndrome.
    Ahn CH; Lee C; Shim J; Kong SH; Kim SJ; Kim YH; Lee KE; Shin CS; Kim JH; Choi MH
    J Steroid Biochem Mol Biol; 2021 Jun; 210():105856. PubMed ID: 33647522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRKAR1A-negative familial Cushing's syndrome: two case reports.
    Lim LL; Kitan N; Paramasivam SS; Ratnasingam J; Ibrahim L; Chan SP; Tan AT; Vethakkan SR
    J Med Case Rep; 2015 Dec; 9():277. PubMed ID: 26619967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma steroid hormones in Cushing's syndrome: their relation to cause and clinical manifestations (author's transl)].
    Horio S; Funahashi H; Mizuno S
    Nihon Naibunpi Gakkai Zasshi; 1981 May; 57(5):807-25. PubMed ID: 7286345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone infusion testing in the diagnosis of Cushing's syndrome.
    Tran HA; Petrovsky N
    Endocr J; 2005 Feb; 52(1):103-9. PubMed ID: 15758565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.
    Oldfield EH; Doppman JL; Nieman LK; Chrousos GP; Miller DL; Katz DA; Cutler GB; Loriaux DL
    N Engl J Med; 1991 Sep; 325(13):897-905. PubMed ID: 1652686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmopressin stimulation test for diagnosis of ACTH-dependent Cushing's syndrome.
    Sakai Y; Horiba N; Tozawa F; Sakai K; Kuwayama A; Demura H; Suda T
    Endocr J; 1997 Oct; 44(5):687-95. PubMed ID: 9466324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: cohort study.
    Fardet L; Petersen I; Nazareth I
    BMJ; 2012 Jul; 345():e4928. PubMed ID: 22846415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.